11.07.2015 Views

FA Family Newsletter Fall 04 - Fanconi Anemia Research Fund

FA Family Newsletter Fall 04 - Fanconi Anemia Research Fund

FA Family Newsletter Fall 04 - Fanconi Anemia Research Fund

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Johnathan Eckstadtby Ann EckstadtWe found out that Johnathan had<strong>Fanconi</strong> anemia when he was threeyears old in 1993. It was the worstnews any mother could ever hear andvery hard to accept. Johnathan’scounts remained stable until the year2000 when his hemoglobin droppeddown to 5.2, and he had to have hisfirst red blood cell transfusion. Wehad to choose at that time between abone marrow transplant or startingJohnathan on the steroid Anadrol tostimulate his red blood cells. Wechose to put Johnathan on thesteroid rather than undergo a bonemarrow transplant, to buy somemore time. We knew that theFairview Hospital in Minnesota wasmaking rapid progress in unrelateddonor transplants and felt it wouldbe better to wait for that reason.Johnathan responded well toAnadrol for about three years. Theside effects of Anadrol include adenomasor tumors of the liver. In Augustof 2003 an ultrasound and CT scanshowed that he had a mass in hisliver, and he had to have surgery toJohnathan Eckstadt<strong>FA</strong> families and patients listen to medical presentations at Regional Meeting.<strong>FA</strong> Regional Meeting Held in Los Angeles AreaThirty-two <strong>FA</strong> patients and their families from the West Coast met onSaturday, May 22, 20<strong>04</strong>, in Monrovia, CA, for an <strong>FA</strong> Regional Meeting.Blanche Alter, MD, MPH, National Cancer Institute, provided informationon the basics of <strong>Fanconi</strong> anemia and on the risks of <strong>FA</strong> patients acquiringsolid tumors. David Kutler, MD, New York University, provided specificinformation on the squamous cell cancers of the head and neck that affect <strong>FA</strong>patients, and Susan Rose, MD, Cincinnati Children’s Medical Center, spokeon diabetes and hormonal problems in <strong>FA</strong>. Josef Rosenthal, MD, City ofHope, discussed bone marrow transplants for <strong>Fanconi</strong> anemia patients andprovided a tour of the City of Hope Comprehensive Cancer Center. Asalways, a highlight of the meeting was that <strong>FA</strong> families had the opportunityto meet each other and share their experiences in dealing with <strong>FA</strong>. Ourthanks to the physicians who gave their time and expertise to the <strong>FA</strong> familiesat this meeting. ◆have it removed. The surgeons foundanother small tumor of the samenature while in surgery and removedthat one as well. Johnathan camethrough his surgery with flying colorsand was back on the basketball courtin no time, although he had to stoptaking Anadrol for fear he would getmore tumors. His blood countsbegan dropping, especially his redblood cells. Eventually, he had tohave monthly red blood cell transfusions.Johnathan’s bone marrow transplantin Minnesota was on July 7,20<strong>04</strong>. I asked Johnathan if he wasnervous, because God knows that Iwas! He told me that he was not thatnervous and was glad there was aprocedure out there that could takehis disease away. When the small bagof the new bone marrow was broughtinto the room, it was a very emotionalmoment. I thought that the donorhad a very big heart to want todonate bone marrow so that my soncould live. I remember it describedon someone’s Caringbridge site as abag of gold. The procedure took only30 minutes and, then, a new journeyhad begun. Johnathan hit somerough patches along the way, but healways came through them with acontinued on page 118 <strong>FA</strong> <strong>Family</strong> <strong>Newsletter</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!